New drug YN001 aims to shrink artery plaque in heart disease trial
NCT ID NCT07521007
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times
Summary
This study tests a drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive weekly injections of YN001 or a placebo for 13 weeks. The main goal is to see if YN001 reduces plaque volume in the arteries, as measured by a special CT scan. The trial is not yet recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- YN001 (a drug given by injection)
- What this could lead to
- If it works, this could point toward a new treatment to reduce artery plaque and better manage heart disease.
- What could go wrong
- This is an early Phase 2b trial, so it may not show clear benefit. The drug could have side effects, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital
NOT_YET_RECRUITINGHefei, Anhui, 230001, China
-
Anzhen Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
-
Beijing Jishuitan Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100035, China
-
Cannopy Clinical Research
NOT_YET_RECRUITINGPenrith, New South Wales, 2750, Australia
-
Canopy Clinical Research
NOT_YET_RECRUITINGAltona N., Victoria, 3025, Australia
-
Capital Area Research
NOT_YET_RECRUITINGCamp Hill, Pennsylvania, 17011, United States
-
Clinical Trials Research
NOT_YET_RECRUITINGLincoln, California, 95648, United States
-
Excel Medical Clinical Trials dba Flourish Research - Boca Raton
NOT_YET_RECRUITINGBoca Raton, Florida, 33434, United States
-
Fudan University-Zhongshan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200032, China
-
Fujian Medical University Union Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, 350001, China
-
HCA Florida Heart Institute
NOT_YET_RECRUITINGPetersburg, Florida, 33709, United States
-
Heart Center Research, LLC
NOT_YET_RECRUITINGHuntsville, Alabama, 35801, United States
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NOT_YET_RECRUITINGTorrance, California, 90502, United States
-
Midwest Heart & Vascular Specialists
NOT_YET_RECRUITINGOverland Park, Kansas, 66209, United States
-
North York Diagnostic and Cardiac Center
NOT_YET_RECRUITINGNorth York, Ontario, M6B 3H7, Canada
-
Renji Hospital Shanghai Jiaotong University school of medicine
RECRUITINGShanghai, Shanghai Municipality, 200001, China
-
Southern Illinois University School of Medicine
NOT_YET_RECRUITINGSpringfield, Illinois, 62781, United States
-
Stanford University School of Medicine
NOT_YET_RECRUITINGStanford, California, 94305, United States
-
The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital
NOT_YET_RECRUITINGCincinnati, Ohio, 45219, United States
-
The First Affiliated Hospital of Harbin Medical University
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150001, China
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130033, China
-
The People's Hospital of Liaoning Province
RECRUITINGShenyang, Liaoning, 110015, China
-
The Second Hospital of Tianjin Medical University
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300211, China
-
Tianjin People's Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300121, China
-
Wake Forest University Health Sciences
NOT_YET_RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
NOT_YET_RECRUITINGSt Louis, Missouri, 63110, United States
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, Hubei, 430071, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?